Amgen Dividend
Dividend criteria checks 5/6
Amgen is a dividend paying company with a current yield of 3.85% that is well covered by earnings.
Key information
3.9%
Dividend yield
54%
Payout ratio
| Industry average yield | 2.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$8.52 |
| Earnings per share | US$14.82 |
| Dividend yield forecast in 3Y | 4.4% |
Recent dividend updates
Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year
May 09
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13
Apr 05Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.13
Feb 02Amgen's (NASDAQ:AMGN) Upcoming Dividend Will Be Larger Than Last Year's
Jan 19Recent updates
Amgen Inc. (NASDAQ:AMGN) Shares Could Be 45% Below Their Intrinsic Value Estimate
May 30Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year
May 09These 4 Measures Indicate That Amgen (NASDAQ:AMGN) Is Using Debt Reasonably Well
Apr 29Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13
Apr 05Amgen Inc. (NASDAQ:AMGN) Shares Could Be 37% Below Their Intrinsic Value Estimate
Feb 27Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.13
Feb 02Amgen's (NASDAQ:AMGN) Upcoming Dividend Will Be Larger Than Last Year's
Jan 19Amgen's (NASDAQ:AMGN) Dividend Will Be Increased To $2.13
Jan 03Amgen (NASDAQ:AMGN) Seems To Use Debt Quite Sensibly
Dec 04Is Amgen Inc. (NASDAQ:AMGN) Trading At A 49% Discount?
Oct 14Amgen: As A Defensive Play?
Oct 14HHS buying $290M worth of Amgen drug Nplate for radiation sickness in nuclear emergency
Oct 04Amgen, AstraZeneca's Tezspire for severe asthma gets approval in EU
Sep 21Amgen Lumakras/Vectibix combo shows promise in phase 1 trial in colorectal cancer
Sep 12Amgen announces positive late-stage data for AstraZeneca biosimilar in PNH
Aug 23Amgen: ChemoCentryx Buyout Papers Over Cracks In Long-Term Outlook
Aug 11Is Amgen (NASDAQ:AMGN) A Risky Investment?
Aug 09Amgen to buy ChemoCentryx for $3.7B
Aug 04Amgen: One For The Next Recession
Jul 14Amgen Stock Looks Ready To Break Out
Jul 07Stability and Growth of Payments
| Month | Dividend Per Share (annual) | Avg. Yield (%) |
|---|---|---|
| 12/31/2025 | 9.76 | 4.4% |
| 12/31/2024 | 9.15 | 4.1% |
| 12/31/2023 | 8.48 | 3.8% |
| 6/7/2023 | 8.52 | 3.9% |
| 3/8/2023 | 8.52 | 3.6% |
| 12/13/2022 | 8.52 | 3.4% |
| 11/1/2022 | 7.76 | 2.7% |
| 8/5/2022 | 7.76 | 3.2% |
| 3/2/2022 | 7.76 | 3.2% |
| 12/3/2021 | 7.76 | 3.5% |
| 10/21/2021 | 7.04 | 3.4% |
| 7/30/2021 | 7.04 | 3.2% |
| 3/3/2021 | 7.04 | 2.9% |
| 2/9/2021 | 7.04 | 3% |
| 2/2/2021 | 7.04 | 3% |
| 10/21/2020 | 6.4 | 2.8% |
| 7/23/2020 | 6.4 | 2.6% |
| 3/4/2020 | 6.4 | 2.8% |
| 12/11/2019 | 6.4 | 2.8% |
| 10/22/2019 | 5.8 | 2.6% |
| 8/2/2019 | 5.8 | 2.9% |
| 3/7/2019 | 5.8 | 3.2% |
| 12/7/2018 | 5.8 | 3% |
| 10/23/2018 | 5.28 | 2.7% |
| 7/31/2018 | 5.28 | 2.6% |
| 3/7/2018 | 5.28 | 2.9% |
| 12/12/2017 | 5.28 | 2.9% |
| 10/24/2017 | 4.6 | 2.7% |
| 7/28/2017 | 4.6 | 2.6% |
| 3/7/2017 | 4.6 | 2.8% |
| 12/20/2016 | 4.6 | 2.9% |
| 10/14/2016 | 4 | 2.7% |
| 7/22/2016 | 4 | 2.3% |
| 3/2/2016 | 4 | 2.6% |
| 12/15/2015 | 4 | 2.6% |
| 7/28/2015 | 3.16 | 2% |
| 3/4/2015 | 3.16 | 2% |
| 12/17/2014 | 3.16 | 2% |
| 10/17/2014 | 2.44 | 1.5% |
| 7/25/2014 | 2.44 | 1.8% |
| 3/5/2014 | 2.44 | 2.1% |
| 12/13/2013 | 2.44 | 2.1% |
| 10/16/2013 | 1.88 | 1.6% |
| 7/26/2013 | 1.88 | 1.7% |
| 3/6/2013 | 1.88 | 1.8% |
| 12/13/2012 | 1.88 | 2.2% |
| 10/11/2012 | 1.44 | 1.7% |
| 7/19/2012 | 1.44 | 1.7% |
Stable Dividend: AMGN's dividends per share have been stable in the past 10 years.
Growing Dividend: AMGN's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Amgen Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (AMGN) | 3.9% |
| Market Bottom 25% (US) | 1.6% |
| Market Top 25% (US) | 4.9% |
| Industry Average (Biotechs) | 2.8% |
| Analyst forecast in 3 Years (AMGN) | 4.4% |
Notable Dividend: AMGN's dividend (3.85%) is higher than the bottom 25% of dividend payers in the US market (1.61%).
High Dividend: AMGN's dividend (3.85%) is low compared to the top 25% of dividend payers in the US market (4.88%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (53.7%), AMGN's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (60.4%), AMGN's dividend payments are covered by cash flows.